Title:
ANTIBODY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/156798
Kind Code:
A1
Abstract:
Provided are an antibody that binds to a plasma kallikrein and the use of the antibody in the preparation of a medicament for the prevention or treatment of a disease associated with the plasma kallikrein or with a plasma prekallikrein.
Inventors:
KE XIAO (CN)
FENG XIAO (CN)
LEI GANG (CN)
REN PENGFEI (CN)
LI JIANHONG (CN)
FENG XIAO (CN)
LEI GANG (CN)
REN PENGFEI (CN)
LI JIANHONG (CN)
Application Number:
PCT/CN2022/073460
Publication Date:
July 28, 2022
Filing Date:
January 24, 2022
Export Citation:
Assignee:
CHENGDU KANGHONG BIOTECHNOLOGY CO LTD (CN)
International Classes:
C07K16/40; A61K39/395; A61P7/10; A61P19/02; A61P19/06; A61P35/00; C12N15/13
Domestic Patent References:
| WO2011085103A2 | 2011-07-14 | |||
| WO2020252136A1 | 2020-12-17 | |||
| WO2020186132A1 | 2020-09-17 |
Foreign References:
| CN103635489A | 2014-03-12 | |||
| CN111704672A | 2020-09-25 | |||
| CN105980404A | 2016-09-28 | |||
| CN105985436A | 2016-10-05 | |||
| CN107405399A | 2017-11-28 |
Download PDF:
Previous Patent: EMERGENCY ALTERNATE AIRPORT SELECTION METHOD BASED ON COLLABORATIVE OPTIMIZATION
Next Patent: ANTIBODY AND USE THEREOF
Next Patent: ANTIBODY AND USE THEREOF